The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report

Abstract Background The use of complement inhibition is well established for complement mediated thrombotic microangiopathy, but its role in secondary forms of thrombotic microangiopathy is debated. We here present a case of thrombotic microangiopathy triggered by Capnocytophaga canimorsus, illustra...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Magnus Holter Bjørkto, Andreas Barratt-Due, Ingvild Nordøy, Christina Dörje, Eivind Galteland, Andreas Lind, Abdulkarim Hilli, Pål Aukrust, Geir Mjøen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	BMC 2021-02-01
Sarja:	BMC Infectious Diseases
Aiheet:	Eculizumab Thrombotic microangiopathy Complement Capnocytophaga canimorsus Case report
Linkit:	https://doi.org/10.1186/s12879-021-05789-2
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!